Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Further positive results received from animal studies of La Jolla's xenotransplantation compound

May 5, 1999

Nabi reports preliminary data from Nabi-Altastaph trial in neonates

May 3, 1999

Iomai demonstrates feasibility and safety of transcutaneous immunization

April 30, 1999

PDL issued U.S. patent covering its SMART anti-CD3 antibody

April 30, 1999

Safety and immunogenicity of TA-GW demonstrated in phase IIa study

April 28, 1999

Canadian launch for world's first Lyme disease vaccine

April 28, 1999

Donor bone marrow: an alternative to immunosuppressive drugs in transplantation?

April 26, 1999

New PRIMATIZED anti-CD80 antibodies engineered at Idec

April 26, 1999

Improved antigen response to conjugate vaccine in mature vs. neonatal mice

April 26, 1999

IDEC-131, an inhibitor of B-cell activation for the treatment of autoimmune disorders

April 23, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...